Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c
Tweet
Share
E-mail
Get Alerts RCKT Hot Sheet
Join SI Premium – FREE
Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Software catches a bid as investors rotate ahead of Palantir earnings
- Design Therapeutics modifies Friedreich ataxia trial, posts Q2 2026 loss
- B.Riley Downgrades MSA Safety (MSA) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
